Literature DB >> 23192733

C-terminal trans-activation sub-region of VP16 is uniquely required for forskolin-induced herpes simplex virus type 1 reactivation from quiescently infected-PC12 cells but not for replication in neuronally differentiated-PC12 cells.

Robert J Danaher1, Ross K Cook, Chunmei Wang, Steven J Triezenberg, Robert J Jacob, Craig S Miller.   

Abstract

The HSV-1 tegument protein VP16 contains a trans-activation domain (TAD) that is required for induction of immediate early (IE) genes during lytic infection and induced reactivation from latency. Here we report the differential contributions of the two sub-regions of the TAD in neuronal and non-neuronal cells during activation of IE gene expression, virus replication, and reactivation from quiescently infected (QIF)-PC12 cells. Our studies show that VP16- and chemical (hexamethylenebisacetamide)-induced IE gene activation is attenuated in neuronal cells. Irrespective of neuronal or non-neuronal cell backgrounds, IE gene activation demonstrated a greater requirement for the N-terminal sub-region of VP16 TAD (VP16N) than the C-terminal sub-region (VP16C). In surprising contrast to these findings, a recombinant virus (RP4) containing the VP16N deletion was capable of modest forskolin-induced reactivation whereas a recombinant (RP3) containing a deletion of VP16C was incapable of stress-induced reactivation from QIF-PC12 cells. These unique process-dependent functions of the VP16 TAD sub-regions may be important during particular stages of the virus life cycle (lytic, entrance, and maintenance of a quiescent state and reactivation) when viral DNA would be expected to be differentially modified.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23192733      PMCID: PMC3568243          DOI: 10.1007/s13365-012-0137-7

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  66 in total

1.  Differential positive control by Oct-1 and Oct-2: activation of a transcriptionally silent motif through Oct-1 and VP16 corecruitment.

Authors:  M A Cleary; S Stern; M Tanaka; W Herr
Journal:  Genes Dev       Date:  1993-01       Impact factor: 11.361

2.  Transcriptional activation by the acidic domain of Vmw65 requires the integrity of the domain and involves additional determinants distinct from those necessary for TFIIB binding.

Authors:  S Walker; R Greaves; P O'Hare
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

3.  Interaction between an acidic activator and transcription factor TFIIB is required for transcriptional activation.

Authors:  S G Roberts; I Ha; E Maldonado; D Reinberg; M R Green
Journal:  Nature       Date:  1993-06-24       Impact factor: 49.962

4.  Drosophila TAFII40 interacts with both a VP16 activation domain and the basal transcription factor TFIIB.

Authors:  J A Goodrich; T Hoey; C J Thut; A Admon; R Tjian
Journal:  Cell       Date:  1993-11-05       Impact factor: 41.582

5.  Hexamethylene bisacetamide stimulates herpes simplex virus immediate early gene expression in the absence of trans-induction by Vmw65.

Authors:  M McFarlane; J I Daksis; C M Preston
Journal:  J Gen Virol       Date:  1992-02       Impact factor: 3.891

6.  Pattern of aromatic and hydrophobic amino acids critical for one of two subdomains of the VP16 transcriptional activator.

Authors:  J L Regier; F Shen; S J Triezenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

7.  Mouse Oct-1 contains a composite homeodomain of human Oct-1 and Oct-2.

Authors:  N Suzuki; W Peter; T Ciesiolka; P Gruss; H R Schöler
Journal:  Nucleic Acids Res       Date:  1993-01-25       Impact factor: 16.971

8.  Different activation domains stimulate transcription from remote ('enhancer') and proximal ('promoter') positions.

Authors:  K Seipel; O Georgiev; W Schaffner
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

9.  Transient reversal of episome silencing precedes VP16-dependent transcription during reactivation of latent HSV-1 in neurons.

Authors:  Ju Youn Kim; Angelo Mandarino; Moses V Chao; Ian Mohr; Angus C Wilson
Journal:  PLoS Pathog       Date:  2012-02-23       Impact factor: 6.823

10.  Entry of herpes simplex virus type 1 (HSV-1) into the distal axons of trigeminal neurons favors the onset of nonproductive, silent infection.

Authors:  Wali Hafezi; Eva U Lorentzen; Bodo R Eing; Marcus Müller; Nicholas J C King; Barbara Klupp; Thomas C Mettenleiter; Joachim E Kühn
Journal:  PLoS Pathog       Date:  2012-05-10       Impact factor: 6.823

View more
  4 in total

1.  Lund Human Mesencephalic (LUHMES) Neuronal Cell Line Supports Herpes Simplex Virus 1 Latency In Vitro.

Authors:  Terri G Edwards; David C Bloom
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

2.  Efficacy of Herpes Simplex Virus Vector Encoding the Human Preproenkephalin Gene for Treatment of Facial Pain in Mice.

Authors:  Fei Ma; Chunmei Wang; William E Yoder; Karin N Westlund; Charles R Carlson; Craig S Miller; Robert J Danaher
Journal:  J Oral Facial Pain Headache       Date:  2016

Review 3.  Herpes Simplex Virus Establishment, Maintenance, and Reactivation: In Vitro Modeling of Latency.

Authors:  Nikki M Thellman; Steven J Triezenberg
Journal:  Pathogens       Date:  2017-06-23

Review 4.  Disturbed Yin-Yang balance: stress increases the susceptibility to primary and recurrent infections of herpes simplex virus type 1.

Authors:  Chang Yan; Zhuo Luo; Wen Li; Xue Li; Robert Dallmann; Hiroshi Kurihara; Yi-Fang Li; Rong-Rong He
Journal:  Acta Pharm Sin B       Date:  2019-06-22       Impact factor: 11.413

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.